Putusan “Produk Cacat” Meta: Risiko Tersembunyi yang Belum “Kepikiran” Sama Analis
Meta Platforms bukan sedang mengalami koreksi biasa. Saham ini sedang direklasifikasi — dan pasar sepertinya belum sadar akan hal itu.
Saham ditutup …
Algorithmic Duty of Care
Meta’s “Defective Product” Ruling Is the Risk No Analyst Price Target Has Priced In
Meta Platforms is not in a correction. It is being reclassified — and the market hasn’t caught up.
The stock closed at $572.1 on April 1, 2026, down …